» Articles » PMID: 18560870

Cytokine Polymorphisms Predict the Frequency of Otitis Media As a Complication of Rhinovirus and RSV Infections in Children

Overview
Date 2008 Jun 19
PMID 18560870
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies suggested that the otitis media (OM) complication rate of viral upper respiratory infection (vURI) is conditioned by genes affecting cytokine production. Two hundred and thirty children (114 male; 187 White, 25 Black; aged 1-9.3 years, average=3.6+/-1.6 years) were prospectively followed over the typical cold season for cold-like illness and OM. Nasopharyngeal secretion samples collected during cold-like illness and OM were assayed for upper respiratory viruses and buccal samples were assayed for TNFalpha (-308), IL-10(-1082, -819, -592), IL-6 (-174) and IFN-gamma (+874) polymorphisms. Logistic regression was used to identify genotypes that predict OM coincident with RSV and rhinovirus (RV) infection. Of the 157 children with RV detection (79 male; 132 White, 13 Black, 12 Other; aged 3.6+/-1.5 years), simple logistic regression identified age (B= -0.34, Z= -2.8, P<0.01, OR=0.71), IL-6 (B= -0.76, Z= -3.3, P<0.01, OR=0.47) and IL-10 (B=0.49, Z=2.0, P=0.05, OR=1.6) as significant predictors of OM coincidence. A more complex logistic regression model for RV detection that included selected OM risk factors identified these factors as well as the TNFalpha genotype, OM history, breastfeeding history and daily environment as significant predictors of OM coincidence. Of the 43 children with RSV detection (21 male; 35 White, 5 Black, 3 Other, aged 3.9+/-1.7 years), logistic regression identified IL-10 (B=1.05, Z=2.0, P=0.05, OR=2.9) as a significant predictor of OM coincidence. New OM episodes coincident with evidence of RSV and RV infection were significantly more frequent in children with high production IL-10 phenotypes. The low production IL-6 and high production TNFalpha phenotypes also contributed to OM risk during RV detection. Cytokine polymorphisms may be one of an expectedly large number of genetic factors contributing to the known heritability of OM.

Citing Articles

Landscape of respiratory syncytial virus.

Duan Y, Liu Z, Zang N, Cong B, Shi Y, Xu L Chin Med J (Engl). 2024; 137(24):2953-2978.

PMID: 39501814 PMC: 11706595. DOI: 10.1097/CM9.0000000000003354.


Impacts of circulating cytokine levels and gene polymorphism predisposition on type 1 diabetes mellitus.

Alghamdi A, El-Sherbini S, Shatla I, Mady E, El-Refaei M Ann Pediatr Endocrinol Metab. 2024; 29(4):250-257.

PMID: 39231486 PMC: 11374510. DOI: 10.6065/apem.2346178.089.


Genomics of Otitis Media (OM): Molecular Genetics Approaches to Characterize Disease Pathophysiology.

Giese A, Ali S, Isaiah A, Aziz I, Riazuddin S, Ahmed Z Front Genet. 2020; 11:313.

PMID: 32391049 PMC: 7191070. DOI: 10.3389/fgene.2020.00313.


Comparative Analysis of Microbiome in Nasopharynx and Middle Ear in Young Children With Acute Otitis Media.

Xu Q, Gill S, Xu L, Gonzalez E, E Pichichero M Front Genet. 2019; 10:1176.

PMID: 31803245 PMC: 6877732. DOI: 10.3389/fgene.2019.01176.


Evidence and evidence gaps in the treatment of Eustachian tube dysfunction and otitis media.

Teschner M GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016; 15:Doc05.

PMID: 28025605 PMC: 5169078. DOI: 10.3205/cto000132.


References
1.
Protonotariou E, Malamitsi-Puchner A, Rizos D, Papagianni B, Moira E, Sarandakou A . Age-related differentiations of Th1/Th2 cytokines in newborn infants. Mediators Inflamm. 2004; 13(2):89-92. PMC: 1781545. DOI: 10.1080/09629350410001688468. View

2.
Mandel E, Doyle W, Winther B, Alper C . The incidence, prevalence and burden of OM in unselected children aged 1-8 years followed by weekly otoscopy through the "common cold" season. Int J Pediatr Otorhinolaryngol. 2008; 72(4):491-9. PMC: 2292124. DOI: 10.1016/j.ijporl.2007.12.008. View

3.
Doyle W, Skoner D, Gentile D . Nasal cytokines as mediators of illness during the common cold. Curr Allergy Asthma Rep. 2005; 5(3):173-81. PMC: 7089508. DOI: 10.1007/s11882-005-0034-8. View

4.
Daly K, Rovers M, Hoffman H, Uhari M, Casselbrant M, Zielhuis G . Recent advances in otitis media. 1. Epidemiology, natural history, and risk factors. Ann Otol Rhinol Laryngol Suppl. 2005; 194:8-15. DOI: 10.1177/00034894051140s104. View

5.
Joki-Erkkila V, Puhakka H, Hurme M . Cytokine gene polymorphism in recurrent acute otitis media. Arch Otolaryngol Head Neck Surg. 2002; 128(1):17-20. DOI: 10.1001/archotol.128.1.17. View